|
|
DSpace at RU >
Search Results
Results 1-37 of 37.
Item hits:
| Full Text | Issue Date | Title | Author(s) |  | 2011 | Serum hepcidin: reference ranges and biochemical correlates in the general population | Galesloot, T.E.; Vermeulen, S.; Geurts-Moespot, A.; Klaver, S.M.; Kroot, J.J.C.; Tienoven, D. van; Wetzels, J.F.M.; Kiemeney, L.A.L.M.; Sweep, F.C.; Heijer, M. den; Swinkels, D.W. |
 | 2010 | Polyclonal antibodies against kallikrein-related peptidase 4 (KLK4): immunohistochemical assessment of KLK4 expression in healthy tissues and prostate cancer. | Seiz, L.; Kotzsch, M.; Grebenchtchikov, N.J.; Geurts-Moespot, A.; Fuessel, S.; Goettig, P.; Gkazepis, A.; Wirth, M.P.; Schmitt, M.; Lossnitzer, A.; Sweep, F.C.; Magdolen, V. |
| | 2010 | Immunochemical and mass-spectrometry-based serum hepcidin assays for iron metabolism disorders. | Kroot, J.J.C.; Laarakkers, J.M.M.; Geurts-Moespot, A.; Grebenchtchikov, N.J.; Pickkers, P.; Ede, A.E. van; Peters, H.P.E.; Dongen-Lases, E. van; Wetzels, J.F.M.; Sweep, F.C.; Tjalsma, H.; Swinkels, D.W. |
| | 2009 | Vascular endothelial growth factor in systemic capillary leak syndrome. | Lesterhuis, W.J.; Rennings, A.J.M.; Leenders, W.P.J.; Nooteboom, A.; Punt, C.J.A.; Sweep, C.G.J.; Pickkers, P.; Geurts-Moespot, A.; Laarhoven, H.W.M. van; Vlag, J. van der; Berden, J.H.M.; Postma, C.T.; Meer, J.W.M. van der |
| | 2009 | High-sensitive radioimmunoassay for human serum hepcidin. | Grebenchtchikov, N.J.; Geurts-Moespot, A.; Kroot, J.J.C.; Heijer, M. den; Tjalsma, H.; Swinkels, D.W.; Sweep, C.G.J. |
| | 2008 | PAI-1 levels predict response to fractionated irradiation in 10 human squamous cell carcinoma lines of the head and neck. | Bayer, C.; Schilling, D.; Hoetzel, J.; Egermann, H.P.; Zips, D.; Yaromina, A.; Geurts-Moespot, A.; Sprague, L.D.; Sweep, C.G.J.; Baumann, M.; Molls, M.; Adam, M. |
| | 2008 | Human anti-mouse IgM and IgG responses in ovarian cancer patients after radioimmunotherapy with 90Y-muHMFG1. | Oei, A.L.M.; Sweep, F.C.; Geurts-Moespot, A.; Tienoven, D. van; Mensdorff-Pouilly, S von; Thomas, C.M.G.; Massuger, L.F.A.G. |
| | 2008 | A decrease of plasma macrophage migration inhibitory factor concentration is associated with lower numbers of circulating lymphocytes in experimental Plasmodium falciparum malaria. | Mast, Q. de; Sweep, F.C.; McCall, M.; Geurts-Moespot, A.; Hermsen, C.; Calandra, T.; Netea, M.G.; Sauerwein, R.W.; Ven, A.J.A.M. van der |
| | 2008 | Components of the plasminogen activator system and their complexes in renal cell and bladder cancer: comparison between normal and matched cancerous tissues. | Span, P.N.; Witjes, J.A.M.; Grebenchtchikov, N.; Geurts-Moespot, A.; Moonen, P.M.J.; Aalders, T.W.; Vriesema, J.L.J.; Kiemeney, L.A.L.M.; Schalken, J.A.; Sweep, F.C. |
| | 2008 | Protein kinase Cdelta expression in breast cancer as measured by real-time PCR, western blotting and ELISA. | McKiernan, E.; O'Brien, K.; Grebenchtchikov, N.; Geurts-Moespot, A.; Sieuwerts, A.M.; Martens, J.W.; Magdolen, V.; Evoy, D.; McDermott, E.; Crown, J.; Sweep, F.C.; Duffy, M.J. |
| | 2007 | Identification and characterization of multiple species of tenascin-X in human serum. | Egging, D.; Peeters, A.C.T.; Grebenchtchikov, N.I.; Geurts-Moespot, A.; Sweep, C.G.J.; Heijer, M. den; Schalkwijk, J. |
| | 2007 | Development of ELISAs for quantification of HMFG1-specific human anti-mouse IgG and IgM antibodies. | Oei, A.L.M.; Boerman, O.C.; Geurts-Moespot, A.; Eerd-Vismale, J.E.M. van; Tienoven, D. van; Courtenay-Luck, N.; Thomas, C.M.G.; Massuger, L.F.A.G.; Sweep, C.G.J. |
| | 2007 | Complex congenital malformations and the impact of the plasminogen activator system and beta-hCG in amniotic fluid. | Verkleij-Hagoort, A.C.; Ursem, N.T.C.; Hop, W.C.J.; Geurts-Moespot, A.; Steegers, E.A.P.; Sweep, C.G.J.; Steegers-Theunissen, R.P.M. |
| | 2007 | Serum and BAL macrophage migration inhibitory factor levels in HIV infected Tanzanians with pulmonary tuberculosis or other lung diseases. | Kibiki, G.S.; Ven, A.J.A.M. van der; Geurts-Moespot, A.; Shao, J.F.; Calandra, T.; Sweep, C.G.J.; Dolmans, W.M.V. |
 | 2007 | Induction of plasminogen activator inhibitor type-1 (PAI-1) by hypoxia and irradiation in human head and neck carcinoma cell lines. | Schilling, D.; Bayer, C.; Geurts-Moespot, A.; Sweep, C.G.J.; Pruschy, M.; Mengele, K.; Sprague, L.D.; Molls, M. |
| | 2007 | Association between high levels of blood macrophage migration inhibitory factor, inappropriate adrenal response, and early death in patients with severe sepsis. | Emonts, M.; Sweep, C.G.J.; Grebenchtchikov, N.I.; Geurts-Moespot, A.; Knaup, M.; Chanson, A.L.; Erard, V.; Renner, P.; Hermans, P.W.M.; Hazelzet, J.A.; Calandra, T. |
| | 2007 | Possible role of the plasminogen activation system in human subfertility. | Ebisch, I.M.W.; Steegers-Theunissen, R.P.M.; Sweep, C.G.J.; Zielhuis, G.A.; Geurts-Moespot, A.; Thomas, C.M.G. |
| | 2007 | Macrophage migration inhibitory factor (MIF) in meningococcal septic shock and experimental human endotoxemia. | Sprong, T.; Pickkers, P.; Geurts-Moespot, A.; Ven-Jongekrijg, J. van der; Neeleman, C.; Knaup, M.; Leroy, D.; Calandra, T.; Meer, J.W.M. van der; Sweep, C.G.J.; Deuren, M. van |
| | 2006 | MIF production by dendritic cells is differentially regulated by Toll-like receptors and increased during rheumatoid arthritis. | Popa, C.; Lieshout, A.W.T. van; Roelofs, M.F.; Geurts-Moespot, A.; Riel, P.L.C.M. van; Calandra, T.; Sweep, C.G.J.; Radstake, T.R.D.J. |
| | 2006 | Protein chip based miniaturized assay for the simultaneous quantitative monitoring of cancer biomarkers in tissue extracts. | Weissenstein, U.; Schneider, M.J.; Pawlak, M.; Cicenas, J.; Eppenberger-Castori, S.; Oroszlan, P.; Ehret, S.; Geurts-Moespot, A.; Sweep, C.G.J.; Eppenberger, U. |
| | 2006 | Concentrations of plasminogen activators and their inhibitors in blood preconceptionally, during and after pregnancy. | Coolman, M.; Groot, C.J. de; Steegers, E.A.P.; Geurts-Moespot, A.; Thomas, C.M.G.; Steegers-Theunissen, R.P.M.; Sweep, C.G.J. |
| | 2006 | CSF levels of growth factors and plasminogen activators in leptomeningeal metastases. | Langerijt, B. van de; Gijtenbeek, J.M.M.; Reus, H.P.M. de; Sweep, C.G.J.; Geurts-Moespot, A.; Hendriks, J.C.M.; Kappelle, A.C.; Verbeek, M.M. |
| | 2005 | Concerns about mammaglobin assays. | Span, P.N.; Grebenchtchikov, N.I.; Geurts-Moespot, A.; Sweep, C.G.J. |
| | 2005 | CSF levels of angiogenesis-related proteins in patients with leptomeningeal metastases. | Reijneveld, J.C.; Brandsma, D.; Boogerd, W.; Bonfrer, J.G.; Kalmijn, S.; Voest, E.E.; Geurts-Moespot, A.; Visser, M.C.; Taphoorn, M.J.B. |
| | 2005 | Development of a sensitive ELISA for the quantification of human tumour necrosis factor-alpha using 4 polyclonal antibodies. | Grebenchtchikov, N.I.; Ven-Jongekrijg, J. van der; Pesman, G.J.; Geurts-Moespot, A.; Meer, J.W.M. van der; Sweep, C.G.J. |
| | 2005 | Measurement of plasminogen activator system components in plasma and tumor tissue extracts obtained from patients with breast cancer: an EORTC Receptor and Biomarker Group collaboration. | Grebenchtchikov, N.I.; Maguire, T.M.; Riisbro, R.; Geurts-Moespot, A.; O'Donovan, N.; Schmitt, M.; McGreal, G.; McDermott, E.; O'Higgins, N.; Brunner, N.; Sweep, C.G.J.; Duffy, M.J. |
| | 2005 | Correlation of rheumatoid arthritis severity with the genetic functional variants and circulating levels of macrophage migration inhibitory factor. | Radstake, T.R.D.J.; Sweep, C.G.J.; Welsing, P.M.J.; Franke, B.; Vermeulen, S.; Geurts-Moespot, A.; Calandra, T.; Donn, R.; Riel, P.L.C.M. van |
| | 2004 | Application of a newly developed ELISA for BCAR1 protein for prediction of clinical benefit of tamoxifen therapy in patients with advanced breast cancer. | Dorssers, L.C.; Grebenchtchikov, N.J.; Brinkman, A.B.; Look, M.P.; Klijn, J.G.M.; Geurts-Moespot, A.; Span, P.N.; Foekens, J.A.; Sweep, C.G.J. |
| | 2004 | High levels of urinary vascular endothelial growth factor in women with severe preeclampsia. | Roes, E.M.; Steegers, E.A.P.; Thomas, C.M.G.; Geurts-Moespot, A.; Raijmakers, M.; Peters, W.H.M.; Sweep, C.G.J. |
| | 2004 | Development of an ELISA for measurement of BCAR1 protein in human breast cancer tissue. | Grebenchtchikov, N.J.; Brinkman, A.B.; Broekhoven, S.P. van; Jong, D. de; Geurts-Moespot, A.; Span, P.N.; Peters, H.A.; Portengen, H.; Foekens, J.A.; Sweep, C.G.J.; Dorssers, L.C. |
| | 2004 | The complex between urokinase-type plasminogen activator (uPA) and its type-1 inhibitor (PAI-I) independently predicts response to first-line endocrine therapy in advanced breast cancer. | Manders, P.; Tjan-Heijnen, V.C.; Span, P.N.; Grebenchtchikov, N.J.; Geurts-Moespot, A.; Tienoven, D.T. van; Beex, L.V.A.M.; Sweep, C.G.J. |
| | 2004 | The prognostic value of BCAR1 in patients with primary breast cancer. | Dorssers, L.C.; Grebenchtchikov, N.J.; Brinkman, A.B.; Look, M.P.; Broekhoven, S.P. van; Jong, D. de; Peters, H.A.; Portengen, H.; Meijer-van Gelder, M.E.; Klijn, J.G.M.; Tienoven, D.T. van; Geurts-Moespot, A.; Span, P.N.; Foekens, J.A.; Sweep, C.G.J. |
| | 2004 | Complex of urokinase-type plasminogen activator with its type 1 inhibitor predicts poor outcome in 576 patients with lymph node-negative breast carcinoma. | Manders, P.; Tjan-Heijnen, V.C.; Span, P.N.; Grebenchtchikov, N.J.; Geurts-Moespot, A.; Tienoven, D.T. van; Beex, L.V.A.M.; Sweep, C.G.J. |
| | 1997 | A sensitive and robust assay for urokinase and tissue-type plasminogen activators (uPA and tPA) and their inhibitor type I (PAI-1) in breast tumor cytosols | Grebenchtchikov, N.I.; Geurts-Moespot, A.; Witte, J.H. de; Heuvel, J.J.T.M.; Leake, R.; Sweep, C.G.J.; Benraad, T.J. |
| | 1996 | Quality control in quantitation of components of the plasminogen activator system in tumour extracts | Benraad, T.J.; Geurts-Moespot, A.; Grebenchtchikov, N.I.; Witte, J.H. de; Heuvel, J.J.T.M.; Sweep, C.G.J. |
| | 1996 | Immunoassays (ELISA) of urokinase-type plasminogen activator (uPA): report of an EORTC/BIOMED-1 workshop | Benraad, T.J.; Geurts-Moespot, A.; Grondahl-Hansen, J.; Schmitt, M.; Heuvel, J.J.T.M.; Witte, J.H. de; Foekens, J.A.; Leake, R.E.; Brünner, N.; Sweep, C.G.J. |
| | 1995 | The performance of a commercial radioligand binding assay for the epidermal growth factor receptor is comparable to the EORTC standard assay | Oberkanins, C.; Geurts-Moespot, A.; Zeillinger, R.; Kury, F.; Leake, R.; Benraad, T.J. |
1
|
